Clinical review 159: Human immunodeficiency virus/highly active antiretroviral therapy-associated metabolic syndrome: clinical presentation, pathophysiology, and therapeutic strategies

J Clin Endocrinol Metab. 2003 May;88(5):1961-76. doi: 10.1210/jc.2002-021704.

Authors

M K S Leow¹, C L Addy, C S Mantzoros

Affiliation

¹ Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.

PMID: 12727939
DOI: 10.1210/jc.2002-021704

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Review

MeSH terms

Adipose Tissue / metabolism
Antiretroviral Therapy, Highly Active / adverse effects*
HIV Infections / complications*
HIV Infections / drug therapy*
HIV-Associated Lipodystrophy Syndrome / diagnosis
HIV-Associated Lipodystrophy Syndrome / etiology*
HIV-Associated Lipodystrophy Syndrome / physiopathology
HIV-Associated Lipodystrophy Syndrome / therapy
Insulin Resistance
Metabolic Syndrome / diagnosis
Metabolic Syndrome / etiology*
Metabolic Syndrome / physiopathology
Metabolic Syndrome / therapy
Proteins / metabolism
Tomography, X-Ray Computed

Substances

Proteins

Grants and funding